Download the full outcome
Detail of outcome
The Medicines and Healthcare products Regulatory Agency (MHRA) has agreed to reclassify Pirinase Hayfever Relief for Adults 0.05% Nasal Spray (fluticasone propionate) from a pharmacy (P) medicine to a general sales list medicine (GSL).
See the public assessment report for more information.
Detail of feedback received
A total of 11 responses were received, of which 4 were in favour, 4 were not in favour, and 3 were responses with no comment. 1 of the responses was confidential.
Consultation ARM 83 seeks your views on the Pharmacy (P) to General Sales List (GSL) reclassification of Pirinase Hayfever Relief for Adults 0.05% Nasal Spray (fluticasone propionate).